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Summary
Proliferating cells require coordinated gene expression
between the nucleus and mitochondria in order to divide,
ensuring sufficient organelle number in daughter cells [1].
However, the machinery and mechanisms whereby prolifer-
ating cells monitor mitochondria and coordinate organelle
biosynthesis remain poorly understood. Antibiotics inhibit-
ing mitochondrial translation have emerged as therapeutics
for human cancers because they block cell proliferation
[2, 3]. These proliferative defects were attributable tomodest
decreases in mitochondrial respiration [3, 4], even though
tumors are mainly glycolytic [5] and mitochondrial respira-
tory chain function appears to play a minor role in cell prolif-
eration in vivo [6]. Here we challenge this interpretation by
demonstrating that one class of antiproliferative antibiotic
induces stalled mitochondrial ribosomes, which triggers a
mitochondrial ribosome and RNA decay pathway. Rescue
of the stalled mitochondrial ribosomes initiates a retrograde
signaling response to block cell proliferation and occurs
prior to any loss of mitochondrial respiration. The loss of
respiratory chain function is simply a downstream effect of
impaired mitochondrial translation and not the antiprolifera-
tive signal. This mitochondrial ribosome quality-control
pathway is actively monitored in cells and constitutes an
important organelle checkpoint for cell division.
Results and Discussion
In mammals, translation of the 13 mitochondrially encoded
polypeptides occurs on a dedicated set of mitochondrial ribo-
somes (mito-ribosomes) with mechanistic features more
similar to those of prokaryotes than to cytoplasmic ribosomes
[7]. Initiation of mitochondrial protein synthesis requires a
formylated methionine-tRNA [8]. Factors for the removal of
the formyl group and starter methionine, as part of the
N-terminal methionine excision (NME) pathway, are functional
in mitochondria [9, 10]. Peptide deformylase (Pdf) initiates
the pathway catalyzing removal of the formyl group from
the starter methionine as the polypeptide chain emerges
from the ribosomal exit tunnel. Pdf activity can be inhibited*Correspondence: brendan.battersby@helsinki.fipharmacologically with peptide mimetics of the actinonin
class, which are being developed as antiproliferative agents
for human tumors [2]. Chloramphenicol is another well-known
inhibitor of mitochondrial translation elongation, occupying
the ribosomal A-site [11, 12], but with quite a different effect
on cell proliferation [13].
Incubation of immortalized mouse embryonic fibroblasts
(MEFs) with these antibiotics produced an expected time-
dependent loss of mitochondrial respiratory chain com-
ponents of differing severity (Figure 1A). Chloramphenicol
decreased the mitochondrially encoded core subunit of cyto-
chrome oxidase mt-Co1 to almost undetectable levels by
48 hr, whereas the effect with actinonin was modest in
comparison (Figure 1A). The assembly of complex I was also
impaired in proliferating MEFs (Figure 1A). The penetrance
of these two antibiotics on mitochondrial protein synthesis
differs and could be due to their mode of action. However,
a striking feature of the actinonin treatment was loss of mito-
ribosomal proteins, from both the small and large ribosomal
subunits (Figures 1A and 1B). Depletion of mito-ribosomal
proteins was time dependent (Figure 1B), reversible (Fig-
ure 1C), and not due to prior instability of the large and small
mito-ribosomal subunits (Figure 1D). In contrast, chloram-
phenicol had no effect on the abundance of mito-ribosomal
protein (Figure 1A). Moreover, this mito-ribosomal depletion
after actinonin treatment is a conserved mitochondrial re-
sponse to this antibiotic stress as shown by the fact that we
also observed the same result in proliferating human foreskin
cells and a cancer cell line (HeLa) (Figure S1 available online).
Mutations in human mito-ribosomal proteins and defects
in mitochondrial rRNA synthesis or processing can impair
the steady-state level of assembled mito-ribosomal subunits
[14–17]. This effect is specific for either the large or small
subunit, not both subunits simultaneously, and has no adverse
effects on cell proliferation. Actinonin induced a time-
dependent loss of both the mitochondrial 12S and 16S rRNA,
matching the loss of mito-ribosomal subunits (Figure 1E). Sur-
prisingly, there was also depletion of mitochondrial mRNA
transcripts from both the light strand and heavy strand (Fig-
ure 1E). In proliferating cells, mitochondrial RNA species
have relatively short half-lives (25 to 210 min depending
upon the RNA) [18] but can be stabilized with the loss of mito-
chondrial transcription to sustain translation of mitochondrial
proteins for up to 48 hr [19]. Actinonin had no effect on mito-
chondrial tRNA levels (Figure 1F), and mtDNA (Figure 1G)
was also unaffected, suggesting that maintenance and tran-
scription of the mitochondrial genome was not altered. Two
other mitochondrial translation inhibitors, chloramphenicol
and doxycycline [20], had no affect on mitochondrial RNA
levels (Figure 1H), indicating that mitochondrial translation
inhibition per se did not initiate this specific RNA decay. These
results indicate that actinonin incubation leads to the specific
degradation of mito-ribosomes and the rRNA and mRNA pool
in a time-dependent manner.
Actinonin and chloramphenicol had a striking difference on
cell proliferation that did not correlate with the severity of the
mitochondrial respiratory chain reduction. Actinonin produced
a progressive growth arrest, whereas chloramphenicol had no
Figure 1. Actinonin Induces Acute Depletion of Mitochondrial Ribosomes, rRNA, and mRNA and Blocks Cell Proliferation
(A) Actinonin (Act) induces loss of mitochondrial ribosomal protein with a modest decrease of mitochondrial respiratory chain complexes in contrast to the
mitochondrial translation inhibitor chloramphenicol (CA). Immunoblots of MEF total cell lysates treated with antibiotics.
(B) Time-dependent decrease of both large and small mitochondrial ribosomal proteins with actinonin treatment. Immunoblots of MEF total cell lysates
treated with actinonin.
(C) Recovery of mito-ribosomal protein after actinonin removal. Immunoblots of MEF total cell lysates treated with actinonin for 16 hr, then incubated with
fresh medium for the marked times. Left lane (Act) with no washout; right lane (-) untreated control.
(D) Immunoblotting of fractions from linear 10%–30% sucrose density gradients.
(E) Northern blot of total RNA from MEFs treated with actinonin.
(F) Northern blot of mitochondrial tRNAs.
(G) Southern blot of MEF mtDNA.
(H) Northern blot of total RNA from MEFs treated with chloramphenicol or doxycycline for the indicated times.
(I) MEF growth curves with antibiotics. Representative growth curves from three independent experiments.
(J) Immunoblot of MEF total cell lysates after antibiotic treatment.
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536effect on cell proliferation (Figure 1I). Importantly, cotreating
cells with both actinonin and chloramphenicol suppressed
the growth arrest (Figure 1I) and depletion of mito-ribosomal
protein (Figure 1J), suggesting that these phenotypes are
linked, independent of mitochondrial respiratory chain dys-
function, and due to mito-ribosome stress and not off-target
effects of actinonin.
Our data indicate that there is a sudden loss of the mito-
chondrial translation apparatus in tandemwith the antiprolifer-
ative effect of actinonin. We next tested whether de novo
mitochondrial protein synthesis was impaired preceding this
ribosomal and RNA decay by specifically radiolabeling the13 mitochondrially encoded polypeptides [21]. After only 2 hr
of treatment, there was a 40% decrease in the rate of
mitochondrial translation, which was almost completely abol-
ished after 6 hr (Figure 2A). This progressive inhibition of all
mitochondrial protein synthesis could arise from impaired
deformylation of nascent polypeptide chains or stalled mito-
ribosomes. However, mass-spec analysis of the N termini
from mitochondrial polypeptides in the heart indicates that
only mt-Co3 undergoes deformylation [22] and thus would
not account for the observed translation defect (Figure 2A).
How could actinonin induce stalled mito-ribosomes? In
bacteria, Pdf is not a structural component of the ribosome,
Figure 2. Actinonin Induces Stalling of Mitochon-
drial Ribosomes
(A) Synthesis of mitochondrial polypeptides in
MEFs preincubated with actinonin for the indi-
cated time and then pulsed with 35S-Met/Cys.
Right, quantification of the total signal from all
subunits except Nd4 and Nd6.
(B) Immunoblotting of fractions from a linear
10%–30% sucrose density gradient of MEFs
stably expressing HA-tagged peptide deformy-
lase.
(C) Quantification of HA-tagged peptide deformy-
lase accumulation in fractions from sucrose
density gradients where the large ribosomal
subunit sediments. The data represent two inde-
pendent experiments. Extended incubation with
chloramphenicol (CA) does not affect the abun-
dance of Pdf on large subunit. On the right,
representative film exposure showing Pdf-HA
accumulation with actinonin.
(D) Northern blot of total RNA after acidic urea-
PAGE fromMEFs probed with oligos for the mito-
chondrial tRNALeu(CUN) and tRNASer(UCN) showing
accumulation of peptidyl-tRNA (arrow) with 3 hr
of actinonin treatment.
(E) Immunoblot of MEF total cell lysates after anti-
biotic treatment.
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537but instead rapidly binds and dissociates from the ribo-
some surface to sample nascent chains [23]. Mitochondrial
Pdf binds actinonin through an induced fit, similarly to its
endogenous substrates except the antibiotic traps the enzyme
in a final key-lock state [24]. If actinonin trapped Pdf on the
largemito-ribosomal subunit near the exit tunnel, this situation
could generate a steric hindrance to the emergence of nascent
polypeptide chains and account for the generalized transla-
tion defect observed (Figure 2A). Notably, stable expressionof HA-tagged Pdf in MEFs showed that
most of the enzyme did not associate
with either mito-ribosomal subunits or
the monosome (Figures 2B and S2;
Table S1). However, actinonin treatment
leads to a specific increase in the
amount of Pdf cosedimenting with the
large ribosomal subunit, whereas chlor-
amphenicol had no effect (Figure 2C).
Chloramphenicol also stalls mito-ribo-
somes, by binding to the ribosomal
A-site and arresting translation at
random positions along the mRNA, but
with clearly different consequences to
mitochondrial and cellular homeostasis.
Under such a model, stalled nascent
chains emerging from the exit tunnel
would generate a temporary accumula-
tion of polypeptidyl-tRNAs trapped in
the P-site [25] before ribosome quality-
control pathways are triggered [26].
The estimated length of the mito-ribo-
somal exit tunnel is 88 A˚ [27] and would
correspond to a minimum 26 amino
acids (assuming 3.35 A˚ per amino acid)
before tertiary folding of the nascent
chain [28]. Within the first 20 to 40 amino
acid positions of all 13 mitochondrialpolypeptides, leucine and serine are significantly enriched
(Figure S3). To test for the accumulation of polypeptidyl-
tRNA, we probed northern blots of total RNA (which contain
polypeptidyl-tRNAswith less than 80 amino acids [25]) with oli-
gos against tRNALeu(CUN) and tRNASer(UCN) (Figures 2D and S3).
Actinonin treatment led to the accumulation of a peptidyl-
tRNA (Figure 2D). Although the abundance of this peptidyl-
tRNA relative to the charged tRNA is low, it is nonetheless
consistent with the observation that proliferating cells have
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538very little monosome (Figure S2). However, other factors could
also play a role. These data suggest that actinonin impairment
of Pdf leads tomito-ribosome stalling and precedes the abrupt
degradation of mito-ribosomes and RNA. The specificity of
this actinonin-induced translation stress may be a trigger for
the decay pathway.
Rescue mechanisms for stalled ribosomes exist as part of
conserved RNA surveillance pathways found in prokaryotes
and eukaryotes, although so far not documented for organellar
ribosomes [26, 29]. The depletion of mitochondrial rRNA,
mRNA, and mito-ribosomes with actinonin are features ob-
served in no-go decay (NGD) and nonfunctional ribosomal
decay (NRD) described for cytoplasmic ribosomes [26, 29].
These quality-control pathways can initiate by stalled ribo-
somes from either defects in RNA folding or nascent polypep-
tide chains in the ribosome [26]. However, ribosomes are
energetically expensive to synthesize. Initially a rescue path-
way dissociates the stalledmonosome to reuse the assembled
small and large subunits, but in some cases ribosomes cannot
be salvaged and are degraded by the proteasome [26, 29]. To
initiate this rescue requires access to the ribosomal A-site for
translation release factors [26, 29].
Mitochondria have three putative class I translation release
factors lacking codon specificity [30]. The fact that chloram-
phenicol blocks access to the ribosomal A-site and can
suppress the actinonin-mediated growth arrest and mito-ribo-
somal decay indicates that the rescue of these stalled mito-
ribosomes is prevented. However, there was a threshold for
the chloramphenicol-mediated suppression effect, suggesting
that blocking translation per se was not sufficient to prevent
the ribosomal andRNAdecay (Figure 2E). Actinonin incubation
for up to 4 hr can lead to a 60% decrease in mitochondrial
protein synthesis (Figure 2A) and yet subsequent administra-
tion of chloramphenicol can prevent the ribosomal decay
(Figure 2E). Beyond 4 hr of actinonin incubation, the chloram-
phenicol suppression was lost (Figure 2E) even though
between 4 and 6 hr of actinonin treatment there was no detect-
able loss of RNA or mito-ribosomal proteins (Figures 1B and
1E). These data are consistent with the idea that damage or
stress accumulates from rescuing the stalling and when this
level reaches a certain threshold (after 4 hr of actinonin),
a decay pathway initiates. Such a scenario has been postu-
lated for stalling of cytoplasmic ribosomes in eukaryotes [26].
Mito-ribosomes are tightly associated with the inner mito-
chondrial membrane, an interaction mediated in part by
prohibitins [31]. Loss of prohibitins generates fragmented
mitochondria and defects in cell proliferation independent of
cellular ATP levels and respiration [32]. We found that actino-
nin induced a time-dependent fragmentation of the complete
mitochondrial network within 6 hr, whereas chloramphenicol
had no effect (Figure 3A). Opa1 is an inner membrane GTPase
important for membrane fusion and cristae organization and is
proteolytically processed into fivemature isoforms. Cell stress
can induce cleavage of themembrane-anchored long isoforms
(L1 and L2) and membrane fragmentation [33, 34]. Actinonin
also induced loss of the long Opa1 isoforms (Figure 3B),
consistent with themembrane fragmentation. However, block-
ing the rescue of those stalled mito-ribosomes by coincubat-
ing with chloramphenicol suppressed this Opa1 cleavage,
indicating that membrane fragmentation arises as a conse-
quence of the rescue pathway, not simply by loss of mitochon-
drial protein synthesis.
To confirm that actinonin required mito-ribosomes to
induce the Opa1 cleavage, we retrovirally transduced MEFswith the UL12.5 viral gene [35], a mitochondrially targeted
nuclease that eliminates mtDNA and as a result mito-ribo-
somes (Figure 3C). Loss of mito-ribosomes completely abro-
gated the actinonin effect onOpa1 cleavage (Figure 3D). More-
over, depletion of mito-ribosomes with UL12.5 also generated
a severe growth defect insensitive to actinonin (Figure 3E),
which clearly indicates the requirement of mito-ribosomes
for these responses.
To block cell proliferation, a mito-ribosomal rescue pathway
must trigger a retrograde signal from the organelle to the
nucleus to coordinate the response. Mitochondrial retrograde
responses have been identified in eukaryotes for misfolded
proteins and mitochondrial dysfunction [36–38]. To obtain
a more complete picture on the retrograde signaling and
the downstream pathways responsive to this mito-ribosomal
rescue, we analyzed the cellular RNA expression profile by
microarray in MEFs treated with actinonin. After only 6 hr there
were profound changes in nuclear gene expression (Figure 4A;
Table S2). This initial response involves genes enriched in
pathways for cell cycle regulation, p53 signaling, MAPK,
cytosolic translation, and mitochondrial respiratory chain (Fig-
ure 4B). These pathways are critically regulated for cell prolif-
eration [5]. These acute changes in gene expression were
independent of the cytosolic energy sensor Ampk-alpha after
6 hr of actinonin (Figure 4C), suggesting initially that there was
no cellular energy crisis (Figure S4). Overall, the kinetic of these
early gene expression changes is consistent with the rescue of
mito-ribosomes and precedes the degradation of mito-ribo-
somes and RNA, suggesting that the rescue pathway triggers
a retrograde signal to modulate cell proliferation.
Our findings document an organellar ribosomal decay path-
way actively monitored in dividing cells that can arrest cell
proliferation when triggered by actinonin-induced stalling of
mito-ribosomes. There are two components to this mecha-
nism, one activated by the stalling and rescue of mito-ribo-
somes and the other initiating the ribosomal and RNA decay.
Initially, stalled mito-ribosomes would be rescued potentially
through mitochondrial release factors binding to the A-site.
The kinetic of this rescue event (less than 6 hr) suggests that
it initiates the retrograde signaling to halt cell proliferation,
possibly mediated through remodeling of mitochondrial mem-
branes (fragmentation and Opa1 processing). The observation
that chloramphenicol specifically can suppress all of these
effects on the same time scale supports the interpretation
that actinonin-induced stalling triggers rescue of mito-ribo-
somes dependent upon the A-site. However, sustained stall-
ing/rescue of mito-ribosomes is likely to generate a signal
that activates this mitochondrial ribosomal and RNA decay
pathway. Once this threshold has been reached, activation
of the decay pathway cannot be stopped and ensures elimina-
tion of the majority of mito-ribosomes andmitochondrial rRNA
and mRNA. Such a mechanism has been posited for cyto-
plasmic ribosomes [26]. The nature of this damage and retro-
grade signals remain to be determined.
In proliferating cells, thismonitoring is probably proportional
to mitochondrial abundance of the cell and probably accounts
for the sensitivity of leukemia to actinonin [2]. This pathway
indicates the existence of cell-autonomous regulation to cell
proliferation by monitoring mitochondria through a process
independent of energy metabolism and extracellular growth
factors. The physiological relevance of this mito-ribosomal
decay pathway would be important with mtDNA mutations,
particularly with genome deletions or high mutation loads,
which would predictably generate stalled mito-ribosomes
Figure 3. Rescue of Stalled Mitochondrial Ribosomes Fragments Mitochondrial Membranes
(A) MEFs were transfected with GFP-Omp25 and then treated with actinonin (Act), chloramphenicol (CA), or carrier (ETOH). Mitochondrial morphology was
classified into three categories (right, scale bars represent 10 mm). Results represent three independent experiments (n = 100 cells per treatment and
experiment).
(B–D) Immunoblots of MEFs treated with antibiotics.
(B) Time-dependent proteolytic processing of Opa1 only with actinonin treatment, which can be suppressed by chloramphenicol.
(C) Expression of the viral UL12.5 nuclease eliminates mtDNA and the abundance of mitochondrial ribosomes.
(D) Expression of UL12.5 in MEFs prevents the actinonin-mediated proteolytic processing of Opa1.
(E) Crystal violet staining of MEFs retrovirally transduced with an empty vector or UL12.5 grown for 72 hr with or without actinonin.
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539and are known to affect proliferating cells of the hemato-
poietic lineage in humans and mice [39, 40]. It remains to be
determined how such a rescue pathway would function in
postmitotic cells, since these cell types have a higher number
of mitochondria and are more dependent upon aerobic energy
metabolism.
Experimental Procedures
Cell Culture, Retrovirus, Immunoblotting, and Mitochondrial Protein
Synthesis
Mouse embryonic fibroblasts (MEFs) immortalized by retroviral trans-
duction of E7/hTERT [41] were cultured under standard conditions with
DMEM (Lonza) supplemented with 10% fetal bovine serum and 50 mg/mluridine. Cells were treated with actinonin (150 mM), chloramphenicol
(200 mg/ml), or carrier (100% ethanol). For crystal violet staining, cells
were washed with PBS and fixed for 15 min in 100% methanol, followed
by 0.1% crystal violet for 15 min. Growth curves were generated with the
Cell-IQ monitoring culture platform and Cell-IQ Analyzer Pro-Write software
(Chip-Man Technologies). Mouse peptide deformylase was cloned into the
retroviral expression vector pBABE-puro, and UL12.5 (kind gift of James
Smiley) was cloned into pMXs-IRES-Blasticidin. Retrovirus was generated
by transient transfection into the Phoenix amphotropic packaging line.
Proteins were separated by SDS-PAGE and transferred to nitrocellulose
by semi-dry transfer. Primary antibodies used: Mrpl13 and Mrps15 (kind
gift of Nils Go¨ran Larsson), Atg5 (Sigma), HA (Sigma), mt-Co1 (MitoScience),
Ndufa9 (MitoScience), Sdha (MitoScience), Tom20 and Tom40 (Santa Cruz),
Opa1 (BD), and Ampk-alpha and phospho(Thr172)-Ampk-alpha (Cell
Signaling). ECLwas used with film or a Chemi-doc imaging station (BioRAD)
Figure 4. Rescue of Stalled Mitochondrial Ribo-
somes Remodels Nuclear Gene Expression to
Halt Cell Proliferation
(A) Differentially expressed genes by microarray
analysis with actinonin relative to the control
(n = 4, for each time point and the control). Inclu-
sion criteria was at least a 1.5-fold linear change
and p < 0.01 after Benjamini and Hochberg
correction.
(B) KEGG pathway analysis for differentially ex-
pressed genes with actinonin treatment relative
to the control. White boxes indicate pathways
significantly enriched for differentially expressed
genes (minimum two genes in a pathway, Fisher
test p < 0.10) with actinonin treatment compared
to the control.
(C) Immunoblotting of MEFs treated with
actinonin.
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540for signal detection. Representative immunoblotting data were cropped in
Photoshop with only linear corrections applied. Pulse labeling of mitochon-
drial protein synthesis was performed as described [21] with gels rehy-
drated for 4 hr in PBS and Coomassie stained to confirm equal loading.
Southern and Northern Blotting and Microarray
Total DNA was isolated from MEFs and Southern blot as described [42].
Total cellular RNA was isolated with Trizol (Invitrogen) and separated on
1.2% agarose-formaldehyde gels, transferred to Hybond-N+ membrane
(GE Healthcare) by neutral transfer, and then hybridized to 50 radiolabeled
oligonucleotides probes to detect mitochondrial transcripts. Mitochondrial
tRNAs were detected from total RNA separated on 7M urea-PAGE and
hybridized with radiolabeled probes. Gene expression analysis was per-
formed with the Agilent SurePrint G3Mouse GE 83 60KMicroarrays. A total
of four independent samples were used for each actinonin-treated time
point and control. Each individual sample (n = 1) consisted of RNA extracted
from cells of four pooled 10 cm plates.
Isokinetic Sucrose Gradient Assays
MEFs or isolated mitochondria were lysed (50 mM Tris [pH 7.2], 10 mM
Mg(Ac)2, 40 mM NH4Cl, 100 mM KCl, 1% DDM, and 1 mM PMSF) for
20 min on ice followed by centrifugation for 20 min at 20,000 3 g at 4C.
The supernatant was loaded on top of a 16 ml linear 10%–30% sucrose
gradient (50 mM Tris [pH 7.2], 10 mM Mg(Ac)2, 40 mM NH4Cl, 100 mM
KCl, and 1 mM PMSF) and centrifuged for 15 hr at 4C and 74,400 3 g
(SW 32.1 Ti). 24 equal volume fractions were collected from the top and
TCA precipitated. Samples were separated by SDS-PAGE for immunoblot-
ting or liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Fluorescence Microscopy
MEFswere transiently transfected with GFP-omp25 [43], then treated on the
following day with antibiotics or ethanol. Cells were fixed in 4% paraformal-
dehyde and mounted with DABCO/MOWIOL on glass slides for imaging on
a Zeiss Axioplan2 with a 1003 (1.3 NA) objective.Accession Numbers
The GEO accession number for the microarray data is GSE44109.
Supplemental Information
Supplemental Information includes Supplemental Experimental Proce-
dures, four figures, and two tables and can be found with this article online
at http://dx.doi.org/10.1016/j.cub.2013.02.019.
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